232 related articles for article (PubMed ID: 25137427)
1. Prospective study of surgical treatment of acromegaly: effects on ghrelin, weight, adiposity, and markers of CV risk.
Reyes-Vidal C; Fernandez JC; Bruce JN; Crisman C; Conwell IM; Kostadinov J; Geer EB; Post KD; Freda PU
J Clin Endocrinol Metab; 2014 Nov; 99(11):4124-32. PubMed ID: 25137427
[TBL] [Abstract][Full Text] [Related]
2. IGF-1 levels across the spectrum of normal to elevated in acromegaly: relationship to insulin sensitivity, markers of cardiovascular risk and body composition.
Reid TJ; Jin Z; Shen W; Reyes-Vidal CM; Fernandez JC; Bruce JN; Kostadinov J; Post KD; Freda PU
Pituitary; 2015 Dec; 18(6):808-19. PubMed ID: 25907335
[TBL] [Abstract][Full Text] [Related]
3. [Lowered ghrelin levels in acromegaly—normalization after treatment].
Kozakowski J; Rabijewski M; Zgliczyński W
Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
[TBL] [Abstract][Full Text] [Related]
4. Clinical indicators of biochemical remission in acromegaly: does incomplete disease control always mean therapeutic failure?
Damjanovic SS; Neskovic AN; Petakov MS; Popovic V; Macut D; Vukojevic P; Joksimovic MM
Clin Endocrinol (Oxf); 2005 Apr; 62(4):410-7. PubMed ID: 15807870
[TBL] [Abstract][Full Text] [Related]
5. Serum ghrelin levels in acromegaly: effects of surgical and long-acting octreotide therapy.
Freda PU; Reyes CM; Conwell IM; Sundeen RE; Wardlaw SL
J Clin Endocrinol Metab; 2003 May; 88(5):2037-44. PubMed ID: 12727951
[TBL] [Abstract][Full Text] [Related]
6. Body composition in active acromegaly during treatment with octreotide: a double-blind, placebo-controlled cross-over study.
Hansen TB; Gram J; Bjerre P; Hagen C; Bollerslev J
Clin Endocrinol (Oxf); 1994 Sep; 41(3):323-9. PubMed ID: 7955439
[TBL] [Abstract][Full Text] [Related]
7. Perioperative plasma active and total ghrelin levels are reduced in acromegaly when compared with in nonfunctioning pituitary tumours even after normalization of serum GH.
Kawamata T; Inui A; Hosoda H; Kangawa K; Hori T
Clin Endocrinol (Oxf); 2007 Jul; 67(1):140-4. PubMed ID: 17466003
[TBL] [Abstract][Full Text] [Related]
8. Adipose Tissue Redistribution and Ectopic Lipid Deposition in Active Acromegaly and Effects of Surgical Treatment.
Reyes-Vidal CM; Mojahed H; Shen W; Jin Z; Arias-Mendoza F; Fernandez JC; Gallagher D; Bruce JN; Post KD; Freda PU
J Clin Endocrinol Metab; 2015 Aug; 100(8):2946-55. PubMed ID: 26037515
[TBL] [Abstract][Full Text] [Related]
9. Effects of growth hormone deficiency on body composition and biomarkers of cardiovascular risk after definitive therapy for acromegaly.
Lin E; Wexler TL; Nachtigall L; Tritos N; Swearingen B; Hemphill L; Loeffler J; Biller BM; Klibanski A; Miller KK
Clin Endocrinol (Oxf); 2012 Sep; 77(3):430-8. PubMed ID: 22315983
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular risk factors in acromegaly before and after normalization of serum IGF-I levels with the GH antagonist pegvisomant.
Sesmilo G; Fairfield WP; Katznelson L; Pulaski K; Freda PU; Bonert V; Dimaraki E; Stavrou S; Vance ML; Hayden D; Klibanski A
J Clin Endocrinol Metab; 2002 Apr; 87(4):1692-9. PubMed ID: 11932303
[TBL] [Abstract][Full Text] [Related]
11. Normal Insulin-like Growth Factor 1 During Somatostatin Receptor Ligand Treatment Predicts Surgical Cure in Acromegaly.
Losa M; Garbin E; Pedone E; Mortini P
J Clin Endocrinol Metab; 2020 Sep; 105(9):. PubMed ID: 32609842
[TBL] [Abstract][Full Text] [Related]
12. Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly.
Colao A; Attanasio R; Pivonello R; Cappabianca P; Cavallo LM; Lasio G; Lodrini A; Lombardi G; Cozzi R
J Clin Endocrinol Metab; 2006 Jan; 91(1):85-92. PubMed ID: 16263832
[TBL] [Abstract][Full Text] [Related]
13. Impact of tumor characteristics and pre- and postoperative hormone levels on hormonal remission following endoscopic transsphenoidal surgery in patients with acromegaly.
Cardinal T; Rutkowski MJ; Micko A; Shiroishi M; Jason Liu CS; Wrobel B; Carmichael J; Zada G
Neurosurg Focus; 2020 Jun; 48(6):E10. PubMed ID: 32480366
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle sodium and potassium changes after successful surgery in acromegaly: relation to body composition, blood glucose, plasma insulin and blood pressure.
Landin K; Petruson B; Jakobsson KE; Bengtsson BA
Acta Endocrinol (Copenh); 1993 May; 128(5):418-22. PubMed ID: 8317188
[TBL] [Abstract][Full Text] [Related]
15. Changes in metabolic parameters and cardiovascular risk factors after therapeutic control of acromegaly vary with the treatment modality. Data from the Bicêtre cohort, and review of the literature.
Briet C; Ilie MD; Kuhn E; Maione L; Brailly-Tabard S; Salenave S; Cariou B; Chanson P
Endocrine; 2019 Feb; 63(2):348-360. PubMed ID: 30397873
[TBL] [Abstract][Full Text] [Related]
16. Predictors of surgical outcome and early criteria of remission in acromegaly.
Antunes X; Ventura N; Camilo GB; Wildemberg LE; Guasti A; Pereira PJM; Camacho AHS; Chimelli L; Niemeyer P; Gadelha MR; Kasuki L
Endocrine; 2018 Jun; 60(3):415-422. PubMed ID: 29626274
[TBL] [Abstract][Full Text] [Related]
17. Effect of oral glucose on acylated and total ghrelin secretion in acromegalic patients.
Isidro ML; Nemina R; Garcia-Buela J; Sangiao-Alvarellos S; Cordido F
Neuro Endocrinol Lett; 2007 Oct; 28(5):596-603. PubMed ID: 17984943
[TBL] [Abstract][Full Text] [Related]
18. Surgical management of GH-secreting pituitary adenomas: an outcome study using modern remission criteria.
Kreutzer J; Vance ML; Lopes MB; Laws ER
J Clin Endocrinol Metab; 2001 Sep; 86(9):4072-7. PubMed ID: 11549628
[TBL] [Abstract][Full Text] [Related]
19. Revisiting the Role of Insulin-like Growth Factor-1 Measurement After Surgical Treatment of Acromegaly.
Jung IH; Choi S; Ku CR; Lee SG; Lee EJ; Kim SH; Kim EH
J Clin Endocrinol Metab; 2021 Jun; 106(7):e2589-e2599. PubMed ID: 33738470
[TBL] [Abstract][Full Text] [Related]
20. Decrease of Serum IGF-I following Transsphenoidal Pituitary Surgery for Acromegaly.
Yu M; Bruns DE; Jane JA; Nass RM; Oldfield EH; Vance ML; Thorner MO
Clin Chem; 2017 Feb; 63(2):486-494. PubMed ID: 27974387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
